Diversity of plasmid-mediated carbapenem-hydrolysing oxacillinases among carbapenem-resistant Acinetobacter baumannii isolates from Kingdom of Bahrain

Journal of Antimicrobial Chemotherapy

Volumn 63, Issue 5, 2009, Pages 1071-1073

  Mugnier, Pauline D ^a   Bindayna, Khalid Mubarak ^b   Poirel, Laurent ^a   Nordmann, Patrice ^a  

^a BICÊTRE HOSPITAL   (France)

^b Arabian Gulf University and the Salmaniya Medical Complex   (United States)

Author keywords

lactamases; A. baumannii; Middle east; Resistance

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AZTREONAM; BACTERIAL ENZYME; BACTERIAL RNA; BETA LACTAM ANTIBIOTIC; CARBAPENEM; CEFALOTIN; CEFEPIME; CEFOTAXIME; CEFPIROME; CEFTAZIDIME; CEFUROXIME; EDETIC ACID; IMIPENEM; KANAMYCIN; MEROPENEM; OXACILLINASE; PIPERACILLIN; RIFAMPICIN; RNA 16S; TICARCILLIN; TIMENTIN; UNCLASSIFIED DRUG;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; BACTERIAL COLONIZATION; BACTERIUM ISOLATION; BAHRAIN; DRUG HYDROLYSIS; GENE INSERTION; GENE SEQUENCE; LETTER; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; SEQUENCE ANALYSIS;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANTI-BACTERIAL AGENTS; BAHRAIN; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CARBAPENEMS; HUMANS; MICROBIAL SENSITIVITY TESTS; PLASMIDS;

EID: 64649104322     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkp052     Document Type: Letter

References (9)

1. Poirel L, Nordmann P. Carbapenem resistance in Acinetobacter baumannii: Mechanism and epidemiology. Clin Microbiol Infect 2006; 12: 826-36.
2. Dortet L, Legrand P, Soussy CJ et al. Bacterial identification, clinical significance, and antimicrobial susceptibilities of Acinetobacter ursingii and Acinetobacter schindleri, two frequently misidentified opportunistic pathogens. J Clin Microbiol 2006; 12: 4471-8.
3. OXA-23 in Acinetobacter baumannii. Antimicrob Agents Chemother 2007; 51: 1530-3.
4. Wang H, Guo P, Sun H et al. Molecular epidemiology of clinical isolates of carbapenem-resistant Acinetobacter spp. from Chinese hospitals. Antimicrob Agents Chemother 2007; 51: 4022-8.
5. Lee K, Kim MN, Choi TY et al. Wide dissemination of OXA-type carbapenemases in clinical Acinetobacter spp. isolates from South Korea. Int J Antimicrob Agents 2008; doi:10.1016/ j.ijantimicag.2008.10.009.
6. Lu PL, Doumith M, Livermore DM et al. Diversity of carbapenem resistance mechanisms in Acinetobacter baumannii from a Taiwan hospital: Spread of plasmid-borne OXA-72 carbapenemase. J Antimicrob Chemother 2009; doi:10.1093/jac/dkn553.
7. Mugnier P, Poirel L, Pitout M et al. Carbapenem-resistant and OXA-23-producing Acinetobacter baumannii isolates in the United Arab Emirates. Clin Microbiol Infect 2008; 14: 879-82.
8. El Shafie SS, Alishaq M, Leni Garcia M. Investigation of an outbreak of multidrug-resistant Acinetobacter baumannii in trauma intensive care unit. J Hosp Infect 2004; 56: 101-5.
9. OXA genes among Acinetobacter spp. isolated from patients at Tehran hospitals. Jpn J Infect Dis 2008; 61: 274-8.